Clinical Trial: Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07132567) titled 'Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through Use-result Surveillance' on July 22.

Brief Summary: The purpose of this surveillance is to assess the safety and efficacy of Poteligeo Inj. 20 mg (mogamulizumab) in routine clinical settings.

Study Start Date: May 02

Study Type: OBSERVATIONAL

Condition: Mycosis Fungoides, Sezary Syndrome

Intervention: DRUG: Poteligeo 20mg

Poteligeo 20mg

Recruitment Status: RECRUITING

Sponsor: Kyowa Kirin Co., Ltd.

Disclaimer: Curated by HT Syndication....